Traditional doctors have very little to offer patients struggling with dementia and cognitive decline. From a functional medicine perspective, there is considerably more available.
Dementia is an umbrella term for a range of neurological conditions leading to cognitive loss. Over 55 million people worldwide live with dementia, and current trends suggest that number doubles every twenty years.
Memory change, word-finding difficulty, slowed processing, and mood shifts are the visible layer. Underneath sit inflammation, vascular function, metabolic health, and microbiome status.
Decades of research now confirm what Dr. Kellman has long taught: the gut and brain communicate constantly. A tailored plan can calm neuroinflammation and strengthen brain resilience.
Treatment combines nootropic and neuroplasticity support, IV therapies, microbiome repair, and technologies including NovoTHOR whole-body red light and the Magnesphere. The synergistic effect of this multi-pronged approach has led to successful outcomes for many patients.
Some contributors are modifiable and some are not. Inflammation, metabolic dysfunction, nutrient deficiency, and microbiome disruption can be addressed, and patients often report gains in clarity and function. Dr. Kellman does not frame this as a cure.
The gut and brain are in constant bidirectional communication. Microbiome disruption drives neuroinflammation, and neuroinflammation is a documented feature of cognitive decline. Addressing the gut is a way to reach that inflammation upstream.